Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Kidney Failure, Chronic

3,4-dihydroxyphenylacetic acid has been researched along with Kidney Failure, Chronic in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
"The hypertensive patients with chronic renal failure shared with their hypertensive counterparts without chronic renal failure an impaired DOPA decarboxylation to dopamine."1.29Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency. ( Kuchel, OG; Shigetomi, S, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuchel, OG1
Shigetomi, S1
Nakayama, H1
Inagaki, M1
Ito, S1
Gotoh, Y1
Oguchi, K1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Kidney Failure, Chronic

ArticleYear
Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
    Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:1 Suppl

    Topics: 3,4-Dihydroxyphenylacetic Acid; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Diastole; Dih

1994
Measurement of catecholamine metabolites: assessment of autonomic impairment in diabetic patients treated by hemodialysis.
    Nephron, 2000, Volume: 86, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Diabetic Neuropathies; Dopamine;

2000